Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06472284 · ClinicalTrials.gov registry record · NA

TetraGraph in Rocuronium Infusions

A NA study of Surgery, sponsored by Joseph D. Tobias.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06472284: Active NA study of Surgery, sponsored by Joseph D. Tobias.

NCT06472284 is a NA study of Surgery that is active but no longer recruiting, run by Joseph D. Tobias. The registered enrollment target is 50 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06472284, a NA study of Surgery, is active but no longer recruiting, sponsored by Joseph D. Tobias.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Primary Outcome

Amount of rocuronium administered in a bolus dose during induction of anesthesia.

Conditions Studied

Interventions

  • DEVICE TetraGraph

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-12
Est. Completion 2026-02
Phase NA
Joseph D. Tobias

21 total trials

What the registry record for NCT06472284 still lists

NCT06472284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which TetraGraph is the first listed.

NCT06472284 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06472284 about?

NCT06472284 is a clinical study titled "TetraGraph in Rocuronium Infusions". This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

What is the current status of trial NCT06472284?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-12. Estimated completion is 2026-02.

What conditions does trial NCT06472284 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT06472284?

The interventions under investigation include: TetraGraph (DEVICE).

Who is sponsoring clinical trial NCT06472284?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06472284 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06472284's enrollment target sits among peer trials

50 88th of 120 higher than 27 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06472284, the US trial registry maintained by the National Library of Medicine. NCT06472284 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.